Hyaluronan degrading silica nanoparticles for skin cancer therapy
We report the first nanoformulation of Hyaluronidase (Hyal) and its enhanced adjuvant effect over the free enzyme. Hyaluronic acid (HA) degrading enzyme Hyal was immobilized on 250 nm silica nanoparticles (SiNP) maintaining specific activity of the enzyme via the layer-by-layer self-assembly techniq...
Gespeichert in:
Veröffentlicht in: | Nanoscale 2013-10, Vol.5 (20), p.9690-9698 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 9698 |
---|---|
container_issue | 20 |
container_start_page | 9690 |
container_title | Nanoscale |
container_volume | 5 |
creator | Scodeller, P Catalano, P N Salguero, N Duran, H Wolosiuk, A Soler-Illia, G J A A |
description | We report the first nanoformulation of Hyaluronidase (Hyal) and its enhanced adjuvant effect over the free enzyme. Hyaluronic acid (HA) degrading enzyme Hyal was immobilized on 250 nm silica nanoparticles (SiNP) maintaining specific activity of the enzyme via the layer-by-layer self-assembly technique. This process was characterized by dynamic light scattering (DLS), zeta potential, infrared and UV-Vis spectroscopy, transmission electron microscopy (TEM) and enzymatic activity measurements. The nanoparticles were tested in vivo as adjuvants of carboplatin (CP), peritumorally injected in A375 human melanoma bearing mice and compared with the non-immobilized enzyme, on the basis of equal enzymatic activity. Alcian Blue staining of A375 tumors indicated large overexpression of hyaluronan. At the end of the experiment, tumor volume reduction with SiNP-immobilized Hyal was significantly enhanced compared to non-immobilized Hyal. Field emission scanning electron microscopy (FE-SEM) images together with energy dispersive X-ray spectroscopy (EDS) spectra confirmed the presence of SiNP on the tumor. We mean a proof of concept: this extracellular matrix (ECM) degrading enzyme, immobilized on SiNP, is a more effective local adjuvant of cancer drugs than the non-immobilized enzyme. This could prove useful in future therapies using other or a combination of ECM degrading enzymes. |
doi_str_mv | 10.1039/c3nr02787b |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1448776999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1448776999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-fc43f24b99bf163542a7fdc2bd933612f5f81f0b697a200e028d0b241bb1f3ff3</originalsourceid><addsrcrecordid>eNqNkEFLwzAYhoMobk4v_gDJUYRqki9NmuMY0wkDL3ouSZrMaNfWpD3s31vZnFdP38vHw8vLg9A1JfeUgHqw0ETCZCHNCZoywkkGINnpMQs-QRcpfRAiFAg4RxMGSqiciSmar3a6HmLb6AZXbhN1FZoNTqEOVuPx2XY69sHWLmHfRpw-Q4OtbqyLuH93UXe7S3TmdZ3c1eHO0Nvj8nWxytYvT8-L-TqzkIs-85aDZ9woZTwVkHOmpa8sM5UaF1Lmc19QT4xQUjNCHGFFRQzj1BjqwXuYodt9bxfbr8GlvtyGZF1d68a1Qyop54WUQin1DxRkLgsFckTv9qiNbUrR-bKLYavjrqSk_LFb_tkd4ZtD72C2rjqivzrhG0RZdRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1437578937</pqid></control><display><type>article</type><title>Hyaluronan degrading silica nanoparticles for skin cancer therapy</title><source>MEDLINE</source><source>Royal Society Of Chemistry Journals 2008-</source><source>Alma/SFX Local Collection</source><creator>Scodeller, P ; Catalano, P N ; Salguero, N ; Duran, H ; Wolosiuk, A ; Soler-Illia, G J A A</creator><creatorcontrib>Scodeller, P ; Catalano, P N ; Salguero, N ; Duran, H ; Wolosiuk, A ; Soler-Illia, G J A A</creatorcontrib><description>We report the first nanoformulation of Hyaluronidase (Hyal) and its enhanced adjuvant effect over the free enzyme. Hyaluronic acid (HA) degrading enzyme Hyal was immobilized on 250 nm silica nanoparticles (SiNP) maintaining specific activity of the enzyme via the layer-by-layer self-assembly technique. This process was characterized by dynamic light scattering (DLS), zeta potential, infrared and UV-Vis spectroscopy, transmission electron microscopy (TEM) and enzymatic activity measurements. The nanoparticles were tested in vivo as adjuvants of carboplatin (CP), peritumorally injected in A375 human melanoma bearing mice and compared with the non-immobilized enzyme, on the basis of equal enzymatic activity. Alcian Blue staining of A375 tumors indicated large overexpression of hyaluronan. At the end of the experiment, tumor volume reduction with SiNP-immobilized Hyal was significantly enhanced compared to non-immobilized Hyal. Field emission scanning electron microscopy (FE-SEM) images together with energy dispersive X-ray spectroscopy (EDS) spectra confirmed the presence of SiNP on the tumor. We mean a proof of concept: this extracellular matrix (ECM) degrading enzyme, immobilized on SiNP, is a more effective local adjuvant of cancer drugs than the non-immobilized enzyme. This could prove useful in future therapies using other or a combination of ECM degrading enzymes.</description><identifier>ISSN: 2040-3364</identifier><identifier>EISSN: 2040-3372</identifier><identifier>DOI: 10.1039/c3nr02787b</identifier><identifier>PMID: 23969526</identifier><language>eng</language><publisher>England</publisher><subject>Adjuvants ; Animals ; Antineoplastic Agents - administration & dosage ; Cancer ; Carboplatin - administration & dosage ; Degradation ; Drug Carriers - chemistry ; Enzymes ; Enzymes, Immobilized - chemistry ; Enzymes, Immobilized - metabolism ; Female ; Humans ; Hyaluronic Acid - metabolism ; Hyaluronoglucosaminidase - chemistry ; Hyaluronoglucosaminidase - metabolism ; Melanoma - drug therapy ; Melanoma - pathology ; Mice ; Mice, Nude ; Nanoparticles ; Nanoparticles - chemistry ; Nanostructure ; Porosity ; Self assembly ; Silicon Dioxide - chemistry ; Skin Neoplasms - drug therapy ; Skin Neoplasms - pathology ; Transplantation, Heterologous ; Tumors</subject><ispartof>Nanoscale, 2013-10, Vol.5 (20), p.9690-9698</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-fc43f24b99bf163542a7fdc2bd933612f5f81f0b697a200e028d0b241bb1f3ff3</citedby><cites>FETCH-LOGICAL-c356t-fc43f24b99bf163542a7fdc2bd933612f5f81f0b697a200e028d0b241bb1f3ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23969526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scodeller, P</creatorcontrib><creatorcontrib>Catalano, P N</creatorcontrib><creatorcontrib>Salguero, N</creatorcontrib><creatorcontrib>Duran, H</creatorcontrib><creatorcontrib>Wolosiuk, A</creatorcontrib><creatorcontrib>Soler-Illia, G J A A</creatorcontrib><title>Hyaluronan degrading silica nanoparticles for skin cancer therapy</title><title>Nanoscale</title><addtitle>Nanoscale</addtitle><description>We report the first nanoformulation of Hyaluronidase (Hyal) and its enhanced adjuvant effect over the free enzyme. Hyaluronic acid (HA) degrading enzyme Hyal was immobilized on 250 nm silica nanoparticles (SiNP) maintaining specific activity of the enzyme via the layer-by-layer self-assembly technique. This process was characterized by dynamic light scattering (DLS), zeta potential, infrared and UV-Vis spectroscopy, transmission electron microscopy (TEM) and enzymatic activity measurements. The nanoparticles were tested in vivo as adjuvants of carboplatin (CP), peritumorally injected in A375 human melanoma bearing mice and compared with the non-immobilized enzyme, on the basis of equal enzymatic activity. Alcian Blue staining of A375 tumors indicated large overexpression of hyaluronan. At the end of the experiment, tumor volume reduction with SiNP-immobilized Hyal was significantly enhanced compared to non-immobilized Hyal. Field emission scanning electron microscopy (FE-SEM) images together with energy dispersive X-ray spectroscopy (EDS) spectra confirmed the presence of SiNP on the tumor. We mean a proof of concept: this extracellular matrix (ECM) degrading enzyme, immobilized on SiNP, is a more effective local adjuvant of cancer drugs than the non-immobilized enzyme. This could prove useful in future therapies using other or a combination of ECM degrading enzymes.</description><subject>Adjuvants</subject><subject>Animals</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Cancer</subject><subject>Carboplatin - administration & dosage</subject><subject>Degradation</subject><subject>Drug Carriers - chemistry</subject><subject>Enzymes</subject><subject>Enzymes, Immobilized - chemistry</subject><subject>Enzymes, Immobilized - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Hyaluronic Acid - metabolism</subject><subject>Hyaluronoglucosaminidase - chemistry</subject><subject>Hyaluronoglucosaminidase - metabolism</subject><subject>Melanoma - drug therapy</subject><subject>Melanoma - pathology</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Nanostructure</subject><subject>Porosity</subject><subject>Self assembly</subject><subject>Silicon Dioxide - chemistry</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - pathology</subject><subject>Transplantation, Heterologous</subject><subject>Tumors</subject><issn>2040-3364</issn><issn>2040-3372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEFLwzAYhoMobk4v_gDJUYRqki9NmuMY0wkDL3ouSZrMaNfWpD3s31vZnFdP38vHw8vLg9A1JfeUgHqw0ETCZCHNCZoywkkGINnpMQs-QRcpfRAiFAg4RxMGSqiciSmar3a6HmLb6AZXbhN1FZoNTqEOVuPx2XY69sHWLmHfRpw-Q4OtbqyLuH93UXe7S3TmdZ3c1eHO0Nvj8nWxytYvT8-L-TqzkIs-85aDZ9woZTwVkHOmpa8sM5UaF1Lmc19QT4xQUjNCHGFFRQzj1BjqwXuYodt9bxfbr8GlvtyGZF1d68a1Qyop54WUQin1DxRkLgsFckTv9qiNbUrR-bKLYavjrqSk_LFb_tkd4ZtD72C2rjqivzrhG0RZdRg</recordid><startdate>20131021</startdate><enddate>20131021</enddate><creator>Scodeller, P</creator><creator>Catalano, P N</creator><creator>Salguero, N</creator><creator>Duran, H</creator><creator>Wolosiuk, A</creator><creator>Soler-Illia, G J A A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>JG9</scope><scope>L7M</scope></search><sort><creationdate>20131021</creationdate><title>Hyaluronan degrading silica nanoparticles for skin cancer therapy</title><author>Scodeller, P ; Catalano, P N ; Salguero, N ; Duran, H ; Wolosiuk, A ; Soler-Illia, G J A A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-fc43f24b99bf163542a7fdc2bd933612f5f81f0b697a200e028d0b241bb1f3ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adjuvants</topic><topic>Animals</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Cancer</topic><topic>Carboplatin - administration & dosage</topic><topic>Degradation</topic><topic>Drug Carriers - chemistry</topic><topic>Enzymes</topic><topic>Enzymes, Immobilized - chemistry</topic><topic>Enzymes, Immobilized - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Hyaluronic Acid - metabolism</topic><topic>Hyaluronoglucosaminidase - chemistry</topic><topic>Hyaluronoglucosaminidase - metabolism</topic><topic>Melanoma - drug therapy</topic><topic>Melanoma - pathology</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Nanostructure</topic><topic>Porosity</topic><topic>Self assembly</topic><topic>Silicon Dioxide - chemistry</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - pathology</topic><topic>Transplantation, Heterologous</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scodeller, P</creatorcontrib><creatorcontrib>Catalano, P N</creatorcontrib><creatorcontrib>Salguero, N</creatorcontrib><creatorcontrib>Duran, H</creatorcontrib><creatorcontrib>Wolosiuk, A</creatorcontrib><creatorcontrib>Soler-Illia, G J A A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Nanoscale</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scodeller, P</au><au>Catalano, P N</au><au>Salguero, N</au><au>Duran, H</au><au>Wolosiuk, A</au><au>Soler-Illia, G J A A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyaluronan degrading silica nanoparticles for skin cancer therapy</atitle><jtitle>Nanoscale</jtitle><addtitle>Nanoscale</addtitle><date>2013-10-21</date><risdate>2013</risdate><volume>5</volume><issue>20</issue><spage>9690</spage><epage>9698</epage><pages>9690-9698</pages><issn>2040-3364</issn><eissn>2040-3372</eissn><abstract>We report the first nanoformulation of Hyaluronidase (Hyal) and its enhanced adjuvant effect over the free enzyme. Hyaluronic acid (HA) degrading enzyme Hyal was immobilized on 250 nm silica nanoparticles (SiNP) maintaining specific activity of the enzyme via the layer-by-layer self-assembly technique. This process was characterized by dynamic light scattering (DLS), zeta potential, infrared and UV-Vis spectroscopy, transmission electron microscopy (TEM) and enzymatic activity measurements. The nanoparticles were tested in vivo as adjuvants of carboplatin (CP), peritumorally injected in A375 human melanoma bearing mice and compared with the non-immobilized enzyme, on the basis of equal enzymatic activity. Alcian Blue staining of A375 tumors indicated large overexpression of hyaluronan. At the end of the experiment, tumor volume reduction with SiNP-immobilized Hyal was significantly enhanced compared to non-immobilized Hyal. Field emission scanning electron microscopy (FE-SEM) images together with energy dispersive X-ray spectroscopy (EDS) spectra confirmed the presence of SiNP on the tumor. We mean a proof of concept: this extracellular matrix (ECM) degrading enzyme, immobilized on SiNP, is a more effective local adjuvant of cancer drugs than the non-immobilized enzyme. This could prove useful in future therapies using other or a combination of ECM degrading enzymes.</abstract><cop>England</cop><pmid>23969526</pmid><doi>10.1039/c3nr02787b</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2040-3364 |
ispartof | Nanoscale, 2013-10, Vol.5 (20), p.9690-9698 |
issn | 2040-3364 2040-3372 |
language | eng |
recordid | cdi_proquest_miscellaneous_1448776999 |
source | MEDLINE; Royal Society Of Chemistry Journals 2008-; Alma/SFX Local Collection |
subjects | Adjuvants Animals Antineoplastic Agents - administration & dosage Cancer Carboplatin - administration & dosage Degradation Drug Carriers - chemistry Enzymes Enzymes, Immobilized - chemistry Enzymes, Immobilized - metabolism Female Humans Hyaluronic Acid - metabolism Hyaluronoglucosaminidase - chemistry Hyaluronoglucosaminidase - metabolism Melanoma - drug therapy Melanoma - pathology Mice Mice, Nude Nanoparticles Nanoparticles - chemistry Nanostructure Porosity Self assembly Silicon Dioxide - chemistry Skin Neoplasms - drug therapy Skin Neoplasms - pathology Transplantation, Heterologous Tumors |
title | Hyaluronan degrading silica nanoparticles for skin cancer therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A57%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyaluronan%20degrading%20silica%20nanoparticles%20for%20skin%20cancer%20therapy&rft.jtitle=Nanoscale&rft.au=Scodeller,%20P&rft.date=2013-10-21&rft.volume=5&rft.issue=20&rft.spage=9690&rft.epage=9698&rft.pages=9690-9698&rft.issn=2040-3364&rft.eissn=2040-3372&rft_id=info:doi/10.1039/c3nr02787b&rft_dat=%3Cproquest_cross%3E1448776999%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1437578937&rft_id=info:pmid/23969526&rfr_iscdi=true |